We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Comparison between brodalumab, secukinumab and ixekizumab effectiveness and drug survival: A real‐life experience on 638 patients with psoriasis.
- Authors
Mastorino, Luca; Cariti, Caterina; Susca, Sara; Siliquini, Niccolò; Verrone, Anna; Stroppiana, Elena; Ortoncelli, Michela; Dapavo, Paolo; Quaglino, Pietro; Ribero, Simone
- Abstract
2 Abbreviations: ANOVA, analysis of variance; BMI, body mass index; DLQI, dermatology life quality index; PASI, psoriasis area severity index; PASI, psoriasis area severity index; SD, standard deviation. PASI improvement of 90%, 100% and PASI <3 was registered for each on-treatment patient at 12, 24 and 48 weeks. Different mean PASI at baseline among the treatments limits the evidence on achievement of PASI <3 at earlier time points, and the analysis of observed cases reduces the strength of evidence.
- Subjects
DRUG efficacy; PATIENTS' attitudes; PSORIASIS
- Publication
Experimental Dermatology, 2023, Vol 32, Issue 9, p1591
- ISSN
0906-6705
- Publication type
Article
- DOI
10.1111/exd.14874